These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37480837)

  • 1. Aβ42 fibril and non-fibril oligomers characterization using a nanopipette.
    Abrao-Nemeir I; Meyer N; Nouvel A; Charles-Achille S; Janot JM; Torrent J; Balme S
    Biophys Chem; 2023 Sep; 300():107076. PubMed ID: 37480837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and Fractionation of Heterogeneous Aβ42 Oligomers with Different Aggregation Properties.
    Chen EW; Guo Z
    Methods Mol Biol; 2023; 2551():29-39. PubMed ID: 36310194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
    Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
    J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Amyloid-β Fibrils Using Track-Etched Nanopores: Effect of Geometry and Crowding.
    Meyer N; Arroyo N; Janot JM; Lepoitevin M; Stevenson A; Nemeir IA; Perrier V; Bougard D; Belondrade M; Cot D; Bentin J; Picaud F; Torrent J; Balme S
    ACS Sens; 2021 Oct; 6(10):3733-3743. PubMed ID: 34554735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain.
    Zhong X; Kumar R; Wang Y; Biverstål H; Ingeborg Jegerschöld C; J B Koeck P; Johansson J; Abelein A; Chen G
    ACS Chem Biol; 2022 Aug; 17(8):2201-2211. PubMed ID: 35876740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
    Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
    FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.
    Selivanova OM; Surin AK; Marchenkov VV; Dzhus UF; Grigorashvili EI; Suvorina MY; Glyakina AV; Dovidchenko NV; Galzitskaya OV
    J Alzheimers Dis; 2016 Sep; 54(2):821-30. PubMed ID: 27567850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical aggregation concentration for the formation of early Amyloid-β (1-42) oligomers.
    Novo M; Freire S; Al-Soufi W
    Sci Rep; 2018 Jan; 8(1):1783. PubMed ID: 29379133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
    Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
    BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Secondary Nucleation at the Single Fibril Level from Direct Observations of Aβ42 Aggregation.
    Zimmermann MR; Bera SC; Meisl G; Dasadhikari S; Ghosh S; Linse S; Garai K; Knowles TPJ
    J Am Chem Soc; 2021 Oct; 143(40):16621-16629. PubMed ID: 34582216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
    Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
    J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
    Wu JW; Breydo L; Isas JM; Lee J; Kuznetsov YG; Langen R; Glabe C
    J Biol Chem; 2010 Feb; 285(9):6071-9. PubMed ID: 20018889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the free energies between the excited states of A
    Chakraborty D; Straub JE; Thirumalai D
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):19926-19937. PubMed ID: 32732434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elongation affinity, activation barrier, and stability of Aβ42 oligomers/fibrils in physiological saline.
    Rodriguez RA; Chen LY; Plascencia-Villa G; Perry G
    Biochem Biophys Res Commun; 2017 May; 487(2):444-449. PubMed ID: 28427941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the Template for Oligomer to Fibril Conversion for Amyloid-β (1-42) Oligomers using Hamiltonian Replica Exchange Molecular Dynamics.
    Saha D; Jana B
    Chemphyschem; 2022 Dec; 23(24):e202200393. PubMed ID: 36052514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide.
    Selivanova OM; Surin AK; Ryzhykau YL; Glyakina AV; Suvorina MY; Kuklin AI; Rogachevsky VV; Galzitskaya OV
    Langmuir; 2018 Feb; 34(6):2332-2343. PubMed ID: 29338255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.